Australian Pharmaceutical Industries Ltd
[2020] FWCA 4123
•6 AUGUST 2020
| [2020] FWCA 4123 |
| FAIR WORK COMMISSION |
DECISION |
Fair Work Act 2009
s.185 - Application for approval of a single-enterprise agreement
Australian Pharmaceutical Industries Ltd
(AG2020/1860)
AUSTRALIAN PHARMACEUTICAL INDUSTRIES LAUNCESTON DISTRIBUTION CENTRE ENTERPRISE AGREEMENT 2020
Pharmaceutical industry | |
COMMISSIONER HUNT | BRISBANE, 6 AUGUST 2020 |
Application for approval of the Australian Pharmaceutical Industries Launceston Distribution Centre Enterprise Agreement 2020.
[1] Australian Pharmaceutical Industries Ltd (the Employer) has applied for approval of an enterprise agreement known as the Australian Pharmaceutical Industries Launceston Distribution Centre Enterprise Agreement 2020 (the Agreement). The application was made pursuant to s.185 of the Fair Work Act 2009 (the Act). The Agreement is a single-enterprise agreement.
[2] The Fair Work Commission (the Commission) raised certain concerns regarding the Agreement with the Employer, and as a result, the Employer has provided written undertakings. A copy of the undertakings is attached at Annexure A. Pursuant to s.190(4) of the Act, I sought the views of the employee bargaining representative regarding the undertakings. On 5 August 2020, the employee bargaining representative wrote to my chambers advising that he had no views to raise and agreed with the undertakings provided by the Employer.
[3] I am satisfied that the undertakings will not cause financial detriment to any employee covered by the Agreement and that the undertakings will not result in substantial changes to the Agreement. Pursuant to s.190 of the Act, I accept the undertakings. In accordance with s.201(3) of the Act, I note that the undertakings are taken to be a term of the Agreement.
[4] I have taken into consideration the material filed in the Commission. Subject to the undertakings referred to above, I am satisfied that each of the requirements of ss.186, 187, 188 and 190 as are relevant to this application for approval have been met. The Agreement does not cover all of the employees of the employer, however, taking into account s.186(3) and (3A) I am satisfied that the group of employees was fairly chosen.
[5] The Agreement is approved and, in accordance with s.54 of the Act, will operate from 13 August 2020. The nominal expiry date of the Agreement is 12 June 2022.
COMMISSIONER
Printed by authority of the Commonwealth Government Printer
<AE508674 PR721602>
Annexure A:
0
0
0